Cargando…

Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?

Type 2 diabetes mellitus (T2DM) is suggested to cause an “early vascular aging” phenomenon that is associated with vascular dysfunction, remodeling, and adverse alterations in vascular stiffness. Given that both T2DM and aging are prominent risk factors for cardiovascular disease, the aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: McCallinhart, Patricia E., Sunyecz, Ian L., Trask, Aaron J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196247/
https://www.ncbi.nlm.nih.gov/pubmed/30374313
http://dx.doi.org/10.3389/fphys.2018.01463
_version_ 1783364517008244736
author McCallinhart, Patricia E.
Sunyecz, Ian L.
Trask, Aaron J.
author_facet McCallinhart, Patricia E.
Sunyecz, Ian L.
Trask, Aaron J.
author_sort McCallinhart, Patricia E.
collection PubMed
description Type 2 diabetes mellitus (T2DM) is suggested to cause an “early vascular aging” phenomenon that is associated with vascular dysfunction, remodeling, and adverse alterations in vascular stiffness. Given that both T2DM and aging are prominent risk factors for cardiovascular disease, the aim of this study was to test the hypothesis that coronary resistance microvessel (CRM) remodeling and impairments in flow occur in the compound setting of T2DM and aging. Normal heterozygous Db/db controls and homozygous db/db mice were aged to 16 (young) or 36 (aged) weeks for all experiments and passive pressure myography and echocardiography were used to assess vascular mechanics, and structure. CRM wall thickness was significantly increased at each pressure in aged control mice compared to young control mice (9.4 ± 0.6 vs. 6.8 ± 0.2 μm, respectively, p < 0.001); however, there were no significant differences in CRM wall thickness of aged db/db mice vs. young db/db mice. Aged control mice had a higher medial CSA compared to young control mice (3847 ± 303 vs. 2715 ± 170 μm(2), p < 0.01); however, there were no significant differences in medial CSA of aged db/db mice vs. young db/db mice. Elastic modulus was lower in aged control CRMs vs. young control CRMs (3.5x10(6)± 0.7 × 10(6) vs. 8.7 × 10(6)± 0.6 × 10(6), p < 0.0001). Elastic modulus remained the same in young db/db mice vs. aged db/db mice. These data show that the diabetic CRMs undergo adverse remodeling at an early age, similar to normal aged CRMs, that persists toward senescence, and it further suggests that diabetic CRMs are subject to an early aging phenomenon.
format Online
Article
Text
id pubmed-6196247
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61962472018-10-29 Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging? McCallinhart, Patricia E. Sunyecz, Ian L. Trask, Aaron J. Front Physiol Physiology Type 2 diabetes mellitus (T2DM) is suggested to cause an “early vascular aging” phenomenon that is associated with vascular dysfunction, remodeling, and adverse alterations in vascular stiffness. Given that both T2DM and aging are prominent risk factors for cardiovascular disease, the aim of this study was to test the hypothesis that coronary resistance microvessel (CRM) remodeling and impairments in flow occur in the compound setting of T2DM and aging. Normal heterozygous Db/db controls and homozygous db/db mice were aged to 16 (young) or 36 (aged) weeks for all experiments and passive pressure myography and echocardiography were used to assess vascular mechanics, and structure. CRM wall thickness was significantly increased at each pressure in aged control mice compared to young control mice (9.4 ± 0.6 vs. 6.8 ± 0.2 μm, respectively, p < 0.001); however, there were no significant differences in CRM wall thickness of aged db/db mice vs. young db/db mice. Aged control mice had a higher medial CSA compared to young control mice (3847 ± 303 vs. 2715 ± 170 μm(2), p < 0.01); however, there were no significant differences in medial CSA of aged db/db mice vs. young db/db mice. Elastic modulus was lower in aged control CRMs vs. young control CRMs (3.5x10(6)± 0.7 × 10(6) vs. 8.7 × 10(6)± 0.6 × 10(6), p < 0.0001). Elastic modulus remained the same in young db/db mice vs. aged db/db mice. These data show that the diabetic CRMs undergo adverse remodeling at an early age, similar to normal aged CRMs, that persists toward senescence, and it further suggests that diabetic CRMs are subject to an early aging phenomenon. Frontiers Media S.A. 2018-10-15 /pmc/articles/PMC6196247/ /pubmed/30374313 http://dx.doi.org/10.3389/fphys.2018.01463 Text en Copyright © 2018 McCallinhart, Sunyecz and Trask. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
McCallinhart, Patricia E.
Sunyecz, Ian L.
Trask, Aaron J.
Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title_full Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title_fullStr Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title_full_unstemmed Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title_short Coronary Microvascular Remodeling in Type 2 Diabetes: Synonymous With Early Aging?
title_sort coronary microvascular remodeling in type 2 diabetes: synonymous with early aging?
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196247/
https://www.ncbi.nlm.nih.gov/pubmed/30374313
http://dx.doi.org/10.3389/fphys.2018.01463
work_keys_str_mv AT mccallinhartpatriciae coronarymicrovascularremodelingintype2diabetessynonymouswithearlyaging
AT sunyeczianl coronarymicrovascularremodelingintype2diabetessynonymouswithearlyaging
AT traskaaronj coronarymicrovascularremodelingintype2diabetessynonymouswithearlyaging